Drugs in R&D

Acknowledgement
pp. 313-314(2)
Author: Adis International Limited

Phase II Study of Antineoplaston A10 and AS2-1 in Children with Recurrent and Progressive Multicentric Glioma: A Preliminary Report
pp. 315-326(12)
Authors: Stanislaw R. Burzynski; Robert A. Weaver; Robert I. Lewy; Tomasz J. Janicki; Gabor F. Jurida; Barbara G. Szymkowski; Mohammad I. Khan; Marc Bestak

In Vitro Effects of Selective and Non-Selective Nonsteroidal Anti-Inflammatory Drugs on the Frequency of Sister Chromatid Exchanges
pp. 327-330(4)
Authors: Sükrü Öztürk; Banu G. Köseoglu; Hülya Koçak; Sükrü Palanduz; Kivanç Çefle; Haluk Erkal

Effect of D-003 on a Subconvulsive Dose of Kainic Acid in Rats
pp. 331-336(6)
Authors: Daisy Carbajal; Miriam Noa; Vivian Molina; Rosa Más; María de Lourdes Arruzazabala

Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018
pp. 339-342(4)
Author: Adis International Limited

Icatibant: HOE 140, JE 049, JE049
pp. 343-348(6)
Author: Adis International Limited

Omeprazole/Antacid-Powder Suspension – Santarus: Omeprazole/Sodium Bicarbonate Powder – Santarus, SAN 05
pp. 349-350(2)
Author: Adis International Limited

Palifermin: AMJ 9701, KGF – Amgen, Recombinant Human Keratinocyte Growth Factor, rHu-KGF
pp. 351-354(4)
Author: Adis International Limited

Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E
pp. 355-358(4)
Author: Adis International Limited

Tamibarotene: AM 80, Retinobenzoic Acid, Tamibaro
pp. 359-362(4)
Author: Adis International Limited

Temsirolimus: CCI 779, CCI-779, Cell Cycle Inhibitor-779
pp. 363-367(5)
Author: Adis International Limited

Testosterone Undecanoate – Schering AG
pp. 368-369(2)
Author: Adis International Limited